Developer of immuno-oncolody therapeutics designed to develop biologics to treat cancer. The company’s therapeutics mainly focus on engineering next generation immunotherapies to treat cancer, addressing many of the limitations associated with current therapies, enabling patients to have access to better form of cancer treatment.
